BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30429678)

  • 1. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".
    Niederle MB; Scheuba C; Gessl A; Li S; Koperek O; Bieglmayer C; Riss P; Selberherr A; Niederle B
    Biochem Med (Zagreb); 2018 Oct; 28(3):030710. PubMed ID: 30429678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]   [Full Text] [Related]  

  • 3. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
    Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.
    Allelein S; Ehlers M; Morneau C; Schwartz K; Goretzki PE; Seppel T; Feldkamp J; Krieg A; Knoefel WT; Kuebart A; Haase M; Dringenberg T; Schmid C; Schott M
    Horm Metab Res; 2018 Jan; 50(1):23-28. PubMed ID: 29169190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.
    Fugazzola L; Di Stefano M; Censi S; Repaci A; Colombo C; Grimaldi F; Magri F; Pagotto U; Iacobone M; Persani L; Mian C
    J Endocrinol Invest; 2021 Mar; 44(3):587-597. PubMed ID: 32656666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
    Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
    J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.
    Boschin IM; Torresan F; Toniato A; Zane M; Ide EC; Pennelli G; Rampin L; Colletti PM; Rubello D; Pelizzo MR
    Endocrine; 2014 Apr; 45(3):448-53. PubMed ID: 23884895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thresholds of Basal- and Calcium-Stimulated Calcitonin for Diagnosis of Thyroid Malignancy.
    Băetu M; Olariu CA; Stancu C; Caragheorgheopol A; Ioachim D; Moldoveanu G; Corneci C; Badiu C
    Horm Metab Res; 2021 Dec; 53(12):779-786. PubMed ID: 34687025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Calcium Test for Preoperative Diagnosis of Medullary Thyroid Carcinoma in Patients With Moderately Elevated Basal Calcitonin.
    Tausanovic KM; Zivaljevic VR; Zorić GV; Jovanovic MD; Stepanovic BG; Milenkovic MG; Paunovic IR
    Endocr Pract; 2021 Nov; 27(11):1077-1081. PubMed ID: 34216799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
    Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H
    Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
    Kihara M; Miyauchi A; Kudo T; Hirokawa M; Miya A
    Endocr J; 2016 Jul; 63(7):627-32. PubMed ID: 27097651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows.
    Censi S; Di Stefano M; Repaci A; Benvenuti T; Manso J; Pagotto U; Iacobone M; Barollo S; Bertazza L; Galuppini F; Benna C; Pennelli G; Plebani M; Faggian D; Colombo C; Fugazzola L; Mian C
    Front Endocrinol (Lausanne); 2021; 12():754565. PubMed ID: 34721303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer.
    Diazzi C; Madeo B; Taliani E; Zirilli L; Romano S; Granata AR; De Santis MC; Simoni M; Cioni K; Carani C; Rochira V
    Endocr Pract; 2013; 19(5):769-79. PubMed ID: 23757613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer.
    Gökçay Canpolat A; Şahin M; Ceyhan K; Sak S; Demir Ö; Emral R; Erdoğan MF; Güllü S; Çorapçıoğlu D
    Turk J Med Sci; 2021 Dec; 51(6):3061-3066. PubMed ID: 34519193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
    Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
    Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Basal and Calcium-stimulated Calcitonin Levels with Pathological Findings After Total Thyroidectomy.
    Papadakis G; Keramidas I; Triantafillou E; Kanouta F; Pappa T; Kaltzidou V; Tertipi A; Iordanidou L; Trivizaki E; Vecchini G; Villiotou V; Pappas A
    Anticancer Res; 2015 Jul; 35(7):4251-8. PubMed ID: 26124386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.